Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

EP-017796 is active against drug-resistant bacteria

Oct. 4, 2010

Cationic peptide NP-339 is active against Candida species

Oct. 4, 2010

CMX-001 is not nephrotoxic in patients with viral infections

Oct. 4, 2010

Chitosan-GP is efficacious in ongoing trial in patients with articular cartilage lesions

Oct. 1, 2010

SAR-707 reveals limitations of acyl-CoA desaturase inhibition in metabolic disorders

Oct. 1, 2010

TransVax reduces cytomegalovirus viremia in phase II trial

Oct. 1, 2010

Phase II data show efficacy of Gilead Sciences' Quad anti-HIV regimen through 48 weeks

Oct. 1, 2010

QTc interval is prolonged in myotonic dystrophy type 1 / News in Context

Oct. 1, 2010

CONQUER trial reveals benefits of phentermine/topiramate combination in obesity

Sep. 30, 2010

ARRY-502 well tolerated in phase I study

Sep. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...